Abstract:Cellular interactions with extracellular matrix play essential roles in tumor initiation, progression and metastasis. Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase identified as a key mediator of signaling by integrins, a major family of cell surface receptors for extracellular matrix, as well as other receptors in both normal and cancer cells. FAK is activated by integrins through disruption of an auto-inhibitory intra-molecular interaction between its kinase domain and the amino terminal FERM domain. The activated FAK forms a binary complex with Src family kinases which can phosphorylate other substrates and trigger multiple intracellular signaling pathways to regulate various cellular functions. Subcellular localization of FAK in focal adhesions is essential for FAK signaling, which is another distinguishing feature of the kinase. Integrin-FAK signaling has been shown to activate a number of signaling pathways through phosphorylation and protein-protein interactions to promote tumorigenesis. FAK also plays a prominent role in tumor progression and metastasis through its regulation of both cancer cells and their microenvironments including cancer cell migration, invasion, epithelial to mesenchymal transition, and angiogenesis. More recently, a role for FAK in tumor initiation and progression has been demonstrated directly using xenograft as well as conditional knockout mouse models. In agreement with these experimental data, overexpression and activation of FAK have been found in a variety of human cancers. A number of small molecule inhibitors for FAK have been developed and in various phases of testing for cancer treatments. Overall, the intensive research on FAK signaling in cancer have yielded a wealth of information on this pivotal kinase and these and future studies are leading to potentially novel therapies for cancer.

Protein kinase A and local signaling in cancer

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Dissecting the Circuitry of Protein Kinase A and cAMP Signaling in Cancer Genesis

Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--opportunities, Challenges, and Limitations.

Protein Kinases in Hematological Disorders

PAK signaling in oncogenesis

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

Protein kinase D1 — A targetable mediator of pancreatic cancer development

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

PKIB, a Novel Target for Cancer Therapy

Signal transduction by focal adhesion kinase in cancer

Proteomic and Phosphoproteomic Profiling Reveals the Oncogenic Role of Protein Kinase D Family Kinases in Cholangiocarcinoma

cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach

AKT/PKB Signaling: Navigating Downstream

Protein Kinase A in neurological disorders

Protein Kinases as Tumor Biomarkers and Therapeutic Targets

Adenylate Kinase and Metabolic Signaling in Cancer Cells

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes

Systems-level identification of PKA-dependent signaling in epithelial cells